ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,673Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 2094

$1.75M Total Retail Price of All Prescriptions

Rank: 18 out of 2094

617 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 17,777 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 815 623 1 4
AMLODIPINE BESYLATE 712 571 2 2
CRESTOR 686 568 3 15
SIMVASTATIN 651 527 4 1
METFORMIN HCL 644 484 5 8
LEVOTHYROXINE SODIUM 505 402 6 3
LISINOPRIL 420 317 7 7
METOPROLOL SUCCINATE 416 339 8 9
CARVEDILOL 388 344 9 19
JANUMET 371 259 10 86
METOPROLOL TARTRATE 351 285 11 10
DIOVAN HCT 343 277 12 28
PRAVASTATIN SODIUM 331 274 13 18
ALENDRONATE SODIUM 328 313 14 30
GABAPENTIN 310 211 15 23
DONEPEZIL HCL 300 274 16 20
FLUTICASONE PROPIONATE 298 211 17 41
ATORVASTATIN CALCIUM 296 228 18 5
LOSARTAN POTASSIUM 286 227 19 17
DIOVAN 282 218 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 275 216 21 55
TRAMADOL HCL 273 198 22 33
CLOPIDOGREL 268 226 23 22
TAMSULOSIN HCL 252 235 24 29
ADVAIR DISKUS 250 136 25 36
LOSARTAN-HYDROCHLOROTHIAZIDE 244 196 26 52
PROAIR HFA 242 104 27 45
WARFARIN SODIUM 226 209 28 11
NEXIUM 223 183 29 16
CILOSTAZOL 213 140 30 204
JANUVIA 210 144 31 35
LANTUS SOLOSTAR 207 149 32 76
FUROSEMIDE 205 162 33 6
FENOFIBRATE 198 130 34 104
NAMENDA 176 164 35 32
VENTOLIN HFA 175 126 36 132
ZETIA 168 134 37 79
ATENOLOL 166 122 38 21
LYRICA 166 134 38 85
SPIRIVA 166 130 38 60
RAMIPRIL 165 134 41 48
HYDROCHLOROTHIAZIDE 158 124 42 12
GLIMEPIRIDE 157 129 43 31
DEXILANT 156 107 44 124
TRAMADOL HCL-ACETAMINOPHEN 154 112 45 100
ENALAPRIL MALEATE 150 108 46 25
RANITIDINE HCL 147 127 47 80
PLAVIX 145 122 48 38
EVISTA 141 114 49 131
MELOXICAM 138 98 50 49
ZOLPIDEM TARTRATE 137 93 51 14
CYMBALTA 136 55 52 61
MECLIZINE HCL 131 109 53 103
CLOBETASOL PROPIONATE 125 82 54 160
LOVAZA 120 72 55 53
HYDRALAZINE HCL 119 83 56 89
POLYETHYLENE GLYCOL 3350 118 91 57 75
ACTOS 116 82 58 112
SINGULAIR 113 61 59 64
CLOTRIMAZOLE-BETAMETHASONE 110 88 60 91
FAMOTIDINE 109 87 61 34
AMMONIUM LACTATE 107 85 62 185
SERTRALINE HCL 106 91 63 26
SYMBICORT 102 75 64 149
LANTUS 99 60 65 66
BYSTOLIC 99 53 65 83
SPIRONOLACTONE 98 87 67 93
TRAZODONE HCL 97 79 68 72
SOLARAZE 96 85 69 278
LIDODERM 89 46 70 59
EXELON 88 88 71 111
EXFORGE HCT 87 43 72 195
MONTELUKAST SODIUM 87 43 72 128
DEXAMETHASONE 86 54 74 439
PRANDIN 84 79 75 125
AMLODIPINE BESYLATE-BENAZEPRIL 84 76 75 58
UNIFINE PENTIPS 82 63 77 257
TRIAMCINOLONE ACETONIDE 81 69 78 186
LIPITOR 81 66 78 39
METFORMIN HCL ER 81 66 78 67
PREDNISONE 80 43 81 54
CYCLOBENZAPRINE HCL 80 38 R 81 115
CLONIDINE HCL 76 40 83 62
CIPROFLOXACIN HCL 75 52 84 81
TRILIPIX 75 48 84 156
NAPROXEN 73 38 86 84
AZITHROMYCIN 73 51 86 27
ALLOPURINOL 72 45 88 50
IBUPROFEN 67 41 89 73
VALSARTAN-HYDROCHLOROTHIAZIDE 67 52 89 225
NIFEDIPINE ER 67 52 89 96
METOLAZONE 66 66 92 216
KOMBIGLYZE XR 65 36 93 248
ONGLYZA 65 57 93 134
GLYBURIDE-METFORMIN HCL 63 37 R 95 94
MIRTAZAPINE 63 63 95 43
KETOCONAZOLE 62 38 97 196
LANSOPRAZOLE 61 47 98 144
GLIPIZIDE 61 46 98 82
ROPINIROLE HCL 60 33 100 235
IBANDRONATE SODIUM 59 59 101 140
CITALOPRAM HBR 58 36 102 47
ATENOLOL-CHLORTHALIDONE 58 52 102 220
SULINDAC 58 40 102 491
ACTONEL 57 51 105 151
ISOSORBIDE MONONITRATE ER 56 56 106 57
PANTOPRAZOLE SODIUM 56 43 106 37
INSULIN SYRINGE 55 34 108 143
VOLTAREN 55 47 108 109
ESCITALOPRAM OXALATE 54 49 110 46
HYDROXYZINE HCL 54 32 R 110 232
PROPRANOLOL HCL 53 37 112 245
GLYBURIDE 52 39 R 113 95
NATEGLINIDE 51 30 114 193
BENICAR HCT 50 34 115 133
VIMOVO 50 26 115 526
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.